Par Pharmaceutical, Inc. v. Alkem Laboratories Ltd.
2:23-cv-00400
Overview
Parties
Defendant
Alkem Laboratories Ltd. Operating Company
Represented By
4 Attorneys ListedWiley Rein LLP
1776 K Street NW, Washington, DC 20006
Gillam & Smith, LLP
303 South Washington Avenue, Marshall, TX 75670
Plaintiff
Endo Par Innovation Company, LLC Operating Company
Represented By
8 Attorneys ListedDechert LLP - Philadelphia
2929 Arch St, Cira Centre
Dechert LLP - New Jersey
902 Carnegie Center, Suite 500
Dechert LLP - Philadelphia
2929 Arch St, Cira Centre
Dechert, LLP
3000 El Camino Real, Five Palo Alto Square, Suite 650
Dechert LLP
Cira Centre, 2929 Arch Street
Dechert LLP - Philadelphia
2929 Arch St, Cira Centre
Miller Fair Henry PLLC
1507 Bill Owens Parkway, Longview, TX 75604
Par Pharmaceutical, Inc. Operating Company
Represented By
8 Attorneys ListedDechert LLP - Philadelphia
2929 Arch St, Cira Centre
Dechert LLP - New Jersey
902 Carnegie Center, Suite 500
Dechert LLP - Philadelphia
2929 Arch St, Cira Centre
Dechert, LLP
3000 El Camino Real, Five Palo Alto Square, Suite 650
Dechert LLP
Cira Centre, 2929 Arch Street
Dechert LLP - Philadelphia
2929 Arch St, Cira Centre
Miller Fair Henry PLLC
1507 Bill Owens Parkway, Longview, TX 75604
Consol Defendant
Mankind Pharma Limited NPE (University / Research)
Represented By
4 Attorneys ListedWinston & Strawn LLP - Dallas
2121 N Pearl Street, Suite 900
Winston & Strawn/Chicago
Winston & Strawn/Chicago, 2121 N. Pearl Street
Winston & Strawn LLP - Chicago
35 West Wacker Drive, Suite 4200
Winston & Strawn/Chicago
Winston & Strawn/Chicago, 2121 N. Pearl Street
Technical Advisor
Court & Judges
Court
District Court, E.D. Texas (txed)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 11,717,524 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2022633190 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,602,537 B2 | US Continuation / Sibling | View Official Patent → |
Par Pharmaceutical, Inc. v. Mankind Pharma Limited <b><font color="red">PURSUANT TO COURT ORDER, DOCKET IN LEAD CASE 2:23CV400</font></b>
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11717524
Varenicline compound and process of manufacture thereof
|
Filed: 2022-09-09
Issued: 2023-08-08
|
Active (15.4 yrs remaining)
Expires: 2042-04-15
|
|
|
US11779587
Vareniciline compound and process of manufacture thereof
|
Filed: 2022-12-30
Issued: 2023-10-10
|
Active (15.4 yrs remaining)
Expires: 2042-04-15
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).
Procedural Motions & Interlocutory Orders
Total Motions
60
Dispositive
24
Granted
17
Denied
0
Pending / Review
25
Motions by Category
Key Dispositive Motions & Rulings